Feedback / Questions
Zejula (niraparib) - GSK, J&J, Takeda
Yonsa (abiraterone acetate) - Churchill Pharma, Sun Pharma
Rubraca (rucaparib) - Clovis
Keytruda (pembrolizumab) - Merck (MSD)
Lynparza (olaparib) - Merck (MSD), AstraZeneca
https://www.onclive.com/view/overview-of-therapy-for-mcrpc-parp-inhibitors
May 4, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next